Crossmark

MPC1 deletion is associated with poor prognosis and temozolomide resistance in glioblastoma

Published Online: 2019-06-24

Published Print: 2019-09

Authors

Chai, Yi

Wang, Caixia

Liu, Wei

Fan, Yanghua

Zhang, Yuqi https://orcid.org/0000-0001-6776-840X
License Information

Text and Data Mining valid from 2019-06-24

Version of Record valid from 2019-06-24
More Information

Article History

Received: 20 March 2019

Accepted: 19 June 2019

First Online: 24 June 2019

Compliance with ethical standards

:

: The authors report no conflict of interest concerning the materials or methods used in this study or the findings specified in this paper.

Document is current